Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine and phencyclidine: the good, the bad and the unexpected
David Lodge, Marion Mercier
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4254-4276
Open Access | Times Cited: 166

Showing 26-50 of 166 citing articles:

GluN2D N-Methyl-D-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia
Kiran Sapkota, Zhihao Mao, Paul Synowicki, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 356, Iss. 3, pp. 702-711
Open Access | Times Cited: 61
Structural biology of glutamate receptor ion channels: towards an understanding of mechanism
Ingo H. Greger, Mark L. Mayer
Current Opinion in Structural Biology (2019) Vol. 57, pp. 185-195
Closed Access | Times Cited: 53
Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status
Roberta Celli, Ines Santolini, Gilles van Luijtelaar, et al.
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 4, pp. 341-351
Open Access | Times Cited: 45
Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
Dominika Psiuk, Emilia Nowak, Natalia Dycha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11450-11450
Open Access | Times Cited: 26
Inhibition of NMDA receptors through a membrane-to-channel path
Madeleine R. Wilcox, Aparna Nigam, Nathan G. Glasgow, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Synthesis and Structure–Activity Relationships for Glutamate Transporter Allosteric Modulators
Andréia C. K. Fontana, Adi Narayana Reddy Poli, Jitendra Gour, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6119-6143
Open Access | Times Cited: 5
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures
Hanbo Yao, Xiaodong Wang, Jiaxin Chi, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 964-964
Open Access | Times Cited: 4
Features of biliary tract diseases in ketamine abusers: a systematic review of case reports
Alireza Teymouri, Hadis Nasoori, Maryamsadat Fakheri, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Causes and management of acute oncological pain: a narrative review
Helen Laycock, Candice Ramdin, Justin Grayer, et al.
Anaesthesia (2025)
Open Access
Synaptic Plasticity in the Hippocampus
Tim Bliss, Graham L. Collingridge, Samuel F. Cooke, et al.
Oxford University Press eBooks (2025), pp. 405-500
Closed Access
A rare cause of indeterminate biliary stricture
A Filippidis, Rahul Sethia, Manu Nayar, et al.
Endoscopy (2025) Vol. 57, Iss. S 02, pp. S396-S396
Closed Access
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
Charles F. Zorumski, Peter Nägele, Steven Mennerick, et al.
Frontiers in Psychiatry (2015) Vol. 6
Open Access | Times Cited: 48
Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action
Eric Maltbie, Gopinath S. Kaundinya, Leonard L. Howell
Behavioural Pharmacology (2017) Vol. 28, Iss. 8, pp. 610-622
Open Access | Times Cited: 47
Metabotropic glutamate receptor subtype 3 gates acute stress-induced dysregulation of amygdalo-cortical function
Max E. Joffe, Chiaki I. Santiago, Julie L. Engers, et al.
Molecular Psychiatry (2017) Vol. 24, Iss. 6, pp. 916-927
Open Access | Times Cited: 45
Schizophrenia and neurogenesis: A stem cell approach
Angela Iannitelli, Adele Quartini, Paola Tirassa, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 80, pp. 414-442
Closed Access | Times Cited: 42
A review of the neurobiological underpinning of comorbid substance use and mood disorders
Nieves Gómez‐Coronado, Rickinder Sethi, Chiara C. Bortolasci, et al.
Journal of Affective Disorders (2018) Vol. 241, pp. 388-401
Closed Access | Times Cited: 41
Antidepressant Actions of Ketamine Versus Hydroxynorketamine
Graham L. Collingridge, Yeseul Lee, Zuner A. Bortolotto, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 8, pp. e65-e67
Open Access | Times Cited: 40
Ketamine Corrects Stress-Induced Cognitive Dysfunction through JAK2/STAT3 Signaling in the Orbitofrontal Cortex
Michael S. Patton, Daniel J. Lodge, David A. Morilak, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 6, pp. 1220-1230
Open Access | Times Cited: 40
DARK Classics in Chemical Neuroscience: Phencyclidine (PCP)
Jeanette L. Bertron, Mabel Seto, Craig W. Lindsley
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2459-2474
Closed Access | Times Cited: 39
Fatal Intoxication Involving 3-MeO-PCP: A Case Report and Validated Method
Erica L. Bakota, Crystal Arndt, Amelia Romoser, et al.
Journal of Analytical Toxicology (2016) Vol. 40, Iss. 7, pp. 504-510
Open Access | Times Cited: 38
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review
Thomas J. Moore, Abdallah Alami, G. Caleb Alexander, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 42, Iss. 7, pp. 567-579
Open Access | Times Cited: 20
Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment
Guy A. Higgins, Leo B. Silenieks, Cam MacMillan, et al.
Behavioural Brain Research (2016) Vol. 311, pp. 1-14
Closed Access | Times Cited: 36
Longitudinal two-photon imaging in somatosensory cortex of behaving mice reveals dendritic spine formation enhancement by subchronic administration of low-dose ketamine
Evgeny Pryazhnikov, Ekaterina Mugantseva, Plínio Casarotto, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity
Rachael Ingram, Heather Kang, Stafford L. Lightman, et al.
Neuropharmacology (2018) Vol. 142, pp. 30-40
Open Access | Times Cited: 33
Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction
Emilija Glavonic, Miloš Mitić, Miroslav Adžić
Journal of Neuroscience Research (2022) Vol. 100, Iss. 4, pp. 947-969
Closed Access | Times Cited: 16

Scroll to top